Breast Diseases  >>  pegylated liposomal doxorubicin  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pegylated liposomal doxorubicin / Generic mfg.
NCT00779285 / 2004-001177-25: Safety Study of CAELYX in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines (Study P04057)(TERMINATED)

Terminated
4
1
Europe
Pegylated Liposomal Doxorubicin, SCH 200746
Merck Sharp & Dohme LLC
Breast Neoplasm
08/06
08/06
NCT00604968 / 2006-005592-17: Pegylated Liposomal Doxorubicin (Caelyx(R)) as Monotherapy in Elderly Patients With Locally Advanced and/or Metastatic Breast Cancer (Study P05059)

Terminated
4
25
NA
Caelyx (pegylated liposomal doxorubicin; SCH 200746)
Merck Sharp & Dohme LLC
Breast Neoplasms
10/09
10/09

Download Options